Risk Factors for Diabetic Peripheral Neuropathy and Cardiovascular Autonomic Neuropathy in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study demonstrated that intensive glucose control reduced the risk of developing diabetic peripheral neuropathy (DPN) and cardiovascular autonomic neuropathy (CAN). We evaluated multiple risk factors and phenotypes associated with DPN and CAN in this large, well-characterized cohort of participants with type 1 diabetes, followed for >23 years. DPN was defined by symptoms, signs, and nerve conduction study abnormalities in ≥2 nerves; CAN was assessed using standardized cardiovascular reflex tests. Generalized estimating equation models assessed the association of DPN and CAN with individual risk factors measured repeatedly. During DCCT/EDIC, 33% of participants developed DPN and 44% CAN. Higher mean HbA1c was the most significant risk factor for DPN, followed by older age, longer duration, greater height, macroalbuminuria, higher mean pulse rate, β-blocker use, and sustained albuminuria. The most significant risk factor for CAN was older age, followed by higher mean HbA1c, sustained albuminuria, longer duration of type 1 diabetes, higher mean pulse rate, higher mean systolic blood pressure, β-blocker use, estimated glomerular filtration rate <60 mL/min/1.73 m2, higher most recent pulse rate, and cigarette smoking. These findings identify risk factors and phenotypes of participants with diabetic neuropathy that can be used in the design of new interventional trials and for personalized approaches to neuropathy prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, persons who fail to return for continued anti-VEGF treatments are at risk of losing vision.537,538”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [538]
In the citing paper
“The prevalence of and risk factors for standard resting ECG-derived CAN were similar to previously reported estimates from CARTs.”
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423 · cited 1×
“LDL cholesterol was calculated using the Friedewald equation (17).”
Method(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Self-citationInternational Diabetes Federation 2017
Carracher, A. M., Marathe, P. H., & Close, K. L. (2018) · Journal of Diabetes · doi:10.1111/1753-0407.12644 · Cited by 13,418
Antihyperlipidemic and Biochemical Activities of Mcy Protein in Streptozotocin Induced Diabetic Rats
Marella, S., Maddirela, D. R., Badri, K. R., Jyothi Kumar, M. V., & Chippada, A. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373954 · Cited by 5,938
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.04.025 · Cited by 3,418 · cited 1×
“Although evidence for the benefit of b-blockers in modulating the impaired cardiac autonomic regulation during high sympathetic stress advocates for their use in patients with heart failure and/or post myocardial infarction (38), these agents are not currently recommended for the treatment of CAN (1).”
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 2×
“Although evidence for the benefit of b-blockers in modulating the impaired cardiac autonomic regulation during high sympathetic stress advocates for their use in patients with heart failure and/or post myocardial infarction (38), these agents are not currently recommended for the treatment of CAN (1).”
BackgroundSelf-citationPrevalence of Type 1 and Type 2 Diabetes Among Children and Adolescents From 2001 to 2009
Dabelea, D., Mayer-Davis, E. J., Saydah, S., Imperatore, G., Linder, B., Divers, J., Bell, R., Badaru, A., Talton, J. W., Crume, T., et al. (2014) · JAMA · doi:10.1001/jama.2014.3201 · Cited by 1,412
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
New Horizons in Diabetic Neuropathy: Mechanisms, Bioenergetics, and Pain
Feldman, E. L., Nave, K.-A., Jensen, T. S., & Bennett, D. L. H. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.005 · Cited by 915 · cited 1×
“The mechanisms linking hypertension to DPN are unclear but may involve a complex set of pathways interlinking nerve function and energy production with a dysfunctional neural vascular supply (29).”
BackgroundSelf-citation2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Colvin, M. M., Drazner, M. H., Filippatos, G. S., Fonarow, G. C., Givertz, M. M., et al. (2017) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2017.04.014 · Cited by 770
Dabelea, D., Stafford, J. M., Mayer-Davis, E. J., D’Agostino, R., Dolan, L., Imperatore, G., Linder, B., Lawrence, J. M., Marcovina, S. M., Mottl, A. K., et al. (2017) · JAMA · doi:10.1001/jama.2017.0686 · Cited by 700
Self-citationPrevalence of diagnosed diabetes in adults by diabetes type – United States, 2016
Bullard, K. M., Cowie, C. C., Lessem, S. E., Saydah, S. H., Menke, A., Geiss, L. S., Orchard, T. J., Rolka, D. B., & Imperatore, G. (2018) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6712a2 · Cited by 512
Self-citationMartin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499
Self-citationPrevalence of Diabetes in U.S. Youth in 2009: The SEARCH for Diabetes in Youth Study
Pettitt, D. J., Talton, J., Dabelea, D., Divers, J., Imperatore, G., Lawrence, J. M., Liese, A. D., Linder, B., Mayer-Davis, E. J., Pihoker, C., et al. (2014) · Diabetes Care · doi:10.2337/dc13-1838 · Cited by 428
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408 · cited 5×
“Our findings are in agreement with other studies identifying dyslipidemia as a risk factor in the development and progression of CAN (24,27,28) and DPN (23,27).”
BackgroundResultInfluentialSelf-citationThe Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group (2015) · Diabetes · doi:10.2337/db14-0930 · Cited by 333
Effects of age, sex, and anthropometric factors on nerve conduction measures
Stetson, D. S., Albers, J. W., Silverstein, B. A., & Wolfe, R. A. (1992) · Muscle & Nerve · doi:10.1002/mus.880151007 · Cited by 311
Self-citationPop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Self-citationNot Available, N. A. (1998) · Diabetologia · doi:10.1007/s001250050924 · Cited by 308
Implementation of Treatment Protocols in the Diabetes Control and Complications Trial
Diabetes Control and Complications Trial Research Group (1995) · Diabetes Care · doi:10.2337/diacare.18.3.361 · Cited by 283
Influence of age and height on nerve conduction
Rivner, M. H., Swift, T. R., & Malik, K. (2001) · Muscle & Nerve · doi:10.1002/mus.1124 · Cited by 272
Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications
Sas, K. M., Kayampilly, P., Byun, J., Nair, V., Hinder, L. M., Hur, J., Zhang, H., Lin, C., Qi, N. R., Michailidis, G., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.86976 · Cited by 268 · cited 1×
“The role of dyslipidemia is further supported by recent work in experimental diabetes where tissue-specific changes in fatty acid metabolism are associated with DPN, independent of glycemic control (33).”
BackgroundSelf-citationThe impact of smoking on the development of diabetes and its complications
Śliwińska-Mossoń, M., & Milnerowicz, H. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117701876 · Cited by 249 · cited 2×
“Cigarette smoking has generally been considered a risk factor for DPN (35).”
BackgroundZiegler, D., Zentai, C. P., Perz, S., Rathmann, W., Haastert, B., Döring, A., Meisinger, C., & for the KORA Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1615 · Cited by 210
Risk Factors for Cardiovascular Disease in Type 1 Diabetes
The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Research Group (2016) · Diabetes · doi:10.2337/db15-1517 · Cited by 209
Self-citationOrchard, T. J., Dorman, J. S., Maser, R. E., Becker, D. J., Ellis, D., LaPorte, R. E., Kuller, L. H., Wolfson, S. K., & Drash, A. L. (1990) · Diabetes Care · doi:10.2337/diacare.13.7.741 · Cited by 207
Self-citationRisk Factors for Retinopathy in Type 1 Diabetes: The DCCT/EDIC Study
Hainsworth, D. P., Bebu, I., Aiello, L. P., Sivitz, W., Gubitosi-Klug, R., Malone, J., White, N. H., Danis, R., Wallia, A., Gao, X., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2308 · Cited by 204
Self-citationHypertension as a Risk Factor for Diabetic Neuropathy: A Prospective Study
Forrest, K. Y.-Z., Maser, R. E., Pambianco, G., Becker, D. J., & Orchard, T. J. (1997) · Diabetes · doi:10.2337/diab.46.4.665 · Cited by 201 · cited 6×
“0001 Stimulated C-peptide (nmol/L$100) Duration ,5 years 12 (4, 25) 12 (4, 26) 13 (4, 24) 1 year 0.”
ResultInfluentialSelf-citationDavis, T. M. E., Yeap, B. B., Davis, W. A., & Bruce, D. G. (2008) · Diabetologia · doi:10.1007/s00125-007-0919-2 · Cited by 200 · cited 3×
“4286 Age (years) 27 (22, 32) 26 (21, 31) 29 (23, 34) 5 years 1.”
BackgroundClair, C., Cohen, M. J., Eichler, F., Selby, K. J., & Rigotti, N. A. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3354-y · Cited by 163
Maser, R. E. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.6.1218 · Cited by 138
Sadosky, A., Mardekian, J., Parsons, B., Hopps, M., Bienen, E. J., & Markman, J. D. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.10.013 · Cited by 129 · cited 3×
“History of diabetes Duration of type 1 diabetes (years) 4 (2, 9) 4 (2, 8) 5 (2, 10) 1 year 1.”
BackgroundRisk Factors for Kidney Disease in Type 1 Diabetes
Perkins, B. A., Bebu, I., de Boer, I. H., Molitch, M., Tamborlane, W., Lorenzi, G., Herman, W., White, N. H., Pop-Busui, R., Paterson, A. D., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2062 · Cited by 128
Self-citationSacre, J. W., Franjic, B., Jellis, C. L., Jenkins, C., Coombes, J. S., & Marwick, T. H. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.09.014 · Cited by 123
Pop-Busui, R., Braffett, B. H., Zinman, B., Martin, C., White, N. H., Herman, W. H., Genuth, S., Gubitosi-Klug, R., & the DCCT/EDIC Research Group (2017) · Diabetes Care · doi:10.2337/dc16-1397 · Cited by 116
Self-citationRELATIONSHIP BETWEEN ETHANOL-RELATED DISEASES AND NUTRITIONAL STATUS IN CHRONICALLY ALCOHOLIC MEN
(1993) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045431 · Cited by 108 · cited 6×
“Occasional or regular alcohol use did not increase the risk of DPN over the course of the DCCT/EDIC study in any of the models despite previous research demonstrating that alcohol is a peripheral neurotoxicant (34).”
BackgroundInfluentialEffect of beta-blockade on heart rate variability in decompensated heart failure
Aronson, D., & Burger, A. J. (2001) · International Journal of Cardiology · doi:10.1016/s0167-5273(01)00401-6 · Cited by 85 · cited 1×
“As such, improvement in heart rate variability would be expected, particularly with b1-selective drugs that may augment vagally mediated heart rate variability (3,37).”
BackgroundCardiovascular autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes
Stella, P., Ellis, D., Maser, R. E., & Orchard, T. J. (2000) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(00)00054-4 · Cited by 81
Self-citationYounes, N., Cleary, P. A., Steffes, M. W., de Boer, I. H., Molitch, M. E., Rutledge, B. N., Lachin, J. M., & Dahms, W. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.07901109 · Cited by 61
Self-citation
Research works printed but not linked: 1
- International Diabetes Federation. IDF Diabetes Atlas, 9th edition [Internet], 2019. Available from https://diabetesatlas.org
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationPathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
The Role of Inflammation in Diabetic Retinopathy
Forrester, J. V., Kuffova, L., & Delibegovic, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.583687 · Cited by 432
“Although etiologically different, both conditions are characterized by hyperglycemia and dyslipidemia which are considered major risk factors for development of the shared macrovascular and microvascular complications as well as neurological dysfunction (15); moreover, the two conditions can coexist (4).”
BackgroundElafros, M. A., Andersen, H., Bennett, D. L., Savelieff, M. G., Viswanathan, V., Callaghan, B. C., & Feldman, E. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(22)00188-0 · Cited by 387
Self-citationDiabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“33,34 The number of young individuals diagnosed with T2DM has been increasing.”
Metadata
- Authors
- Braffett, B. H., Gubitosi-Klug, R. A., Albers, J. W., Feldman, E. L., Martin, C. L., White, N. H., Orchard, T. J., Lopes-Virella, M., Lachin, J. M., Pop-Busui, R., & the DCCT/EDIC Research Group
- Affiliations
- George Washington University (US)
- Rainbow Babies & Children’s Hospital, Case Western Reserve University, Cleveland, OH
- University of Michigan (US)
- Washington University in St. Louis (US)
- University of Pittsburgh (US)
- Medical University of South Carolina (US)
- University of Michigan Medical School, Ann Arbor, MI
- Corresponding author
- Braffett, Barbara H.
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2020-02-12
- Volume
- 69
- Issue
- 5
- Pages
- 1000-1010
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC7171957
- OpenAlex
- W3006227931
- Cited by
- 221
- References
- 40
- Citations by year
- 2026: 26 · 2025: 41 · 2024: 45 · 2023: 31 · 2022: 40 · 2021: 24 · 2020: 14
- FWCI
- 20.55
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Diabetes (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u01dk094157-13, UL1TR002345)
- National Institute of Diabetes and Digestive and Kidney Diseases (U01DK094176, U01-DK094157, P30DK092926, P30DK020572, P30DK017047)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, cardiac autonomic neuropathy, type 1 diabetes, risk factors, tight glycemic control, HbA1c, albuminuria, macroalbuminuria, beta-blocker use, pulse rate, cigarette smoking, neuropathy prevention, DCCT/EDIC
- MeSH terms
- Adult, Autonomic Nervous System, Blood Glucose, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Female, Glycated Hemoglobin, Humans, Longitudinal Studies, Male, Risk Factors, Cohort Studies, Multivariate Analysis, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.